Literature DB >> 2666321

Griseofulvin and ketoconazole in the treatment of dermatophyte infections.

D R Lambert1, R J Siegle, C Camisa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2666321     DOI： 10.1111/j.1365-4362.1989.tb01348.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  7 in total

Review 1.  Onychomycosis. Going for cure.

Authors:  A K Gupta; N H Shear
Journal:  Can Fam Physician       Date:  1997-02       Impact factor: 3.275

2.  In Silico Molecular Dynamics of Griseofulvin and Its Derivatives Revealed Potential Therapeutic Applications for COVID-19.

Authors:  Parisa Aris; Masoud Mohamadzadeh; Yulong Wei; Xuhua Xia
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

Review 3.  Treatment and prophylaxis of tinea infections.

Authors:  G E Piérard; J E Arrese; C Piérard-Franchimont
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

4.  A metabolomic perspective of griseofulvin-induced liver injury in mice.

Authors:  Ke Liu; Jiong Yan; Madhav Sachar; Xinju Zhang; Ming Guan; Wen Xie; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2015-09-05       Impact factor: 5.858

Review 5.  The dermatophytes.

Authors:  I Weitzman; R C Summerbell
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 6.  Multipurpose Drugs Active Against Both Plasmodium spp. and Microorganisms: Potential Application for New Drug Development.

Authors:  Takuro Endo; Hitoshi Takemae; Indu Sharma; Tetsuya Furuya
Journal:  Front Cell Infect Microbiol       Date:  2021-12-24       Impact factor: 5.293

7.  Conservation of griseofulvin genes in the gsf gene cluster among fungal genomes.

Authors:  Parisa Aris; Lihong Yan; Yulong Wei; Ying Chang; Bihong Shi; Xuhua Xia
Journal:  G3 (Bethesda)       Date:  2022-02-04       Impact factor: 3.542
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.